Prospects of repair in multiple sclerosis

Journal of the Neurological Sciences

Volumn 277, Issue SUPPL. 1, 2009, Pages

  Yong, V Wee ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cell culture; Glatiramer acetate; Multiple sclerosis; Neuroprotection; Oligodendrocyte; Remyelination

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLATIRAMER; LINGO 1 PROTEIN; PROLACTIN; PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CELL DIFFERENTIATION; CELL TYPE; DEMYELINATION; EDITORIAL; HUMAN; MONOCYTE; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PREGNANCY; PRIORITY JOURNAL; REMYELINIZATION; STEM CELL TRANSPLANTATION; TH2 CELL;

EID: 59249084979     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(09)70006-1     Document Type: Editorial

References (24)

1. Raine C.S., Scheinberg L., and Waltz J.M. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45 (1981) 534-546
2. Prineas J.W., Kwon E.E., Goldenberg P.Z., Ilyas A.A., Quarles R.H., Benjamins J.A., et al. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 61 (1989) 489-503
3. Patrikios P., Stadelmann C., Kutzelnigg A., Rauschka H., Schmidbauer M., Laursen H., et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129 (2006) 3165-3172
4. Kassmann C.M., and Nave K.A. Oligodendroglial impact on axonal function and survival - a hypothesis. Curr Opin Neurol 21 (2008) 235-241
5. Rieckmann P., and Maurer M. Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis. Curr Opin Neurol 15 (2002) 361-370
6. Chandran S., Hunt D., Joannides A., Zhao C., Compston A., and Franklin R.J. Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc London 363 (2008) 171-183
7. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8 (2005) 745-751
8. Mi S., Hu B., Hahm K., Luo Y., Kam Hui E.S., Yuan Q., et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13 (2007) 1228-1233
9. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., and Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339 (1998) 285-291
10. Klipple G.L., and Cecere F.A. Rheumatoid arthritis and pregnancy. Rheum Dis Clin N Am 15 (1989) 213-239
11. Gregg C., Shikar V., Larsen P., Mak G., Chojnacki A., Yong V.W., et al. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27 (2007) 1812-1823
12. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 107 (2000) 161-166
13. Hohlfeld R., Kerschensteiner M., Stadelmann C., Lassmann H., and Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci 27 Suppl 1 (2006) S1-S7
14. Bieber A.J., Kerr S., and Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann Neurol 53 (2003) 680-684
15. Kotter M.R., Setzu A., Sim F.J., Van Rooijen N., and Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35 (2001) 204-212
16. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., and Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4 (2001) 1116-1122
17. Mason J.L., Suzuki K., Chaplin D.D., and Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J Neurosci 21 (2001) 7046-7052
18. Larsen P.H., Wells J.E., Stallcup W.B., Opdenakker G., and Yong V.W. Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci 23 (2003) 11127-11135
19. Franklin R.J., and Kotter M.R. The biology of CNS remyelination: the key to therapeutic advances. J Neurol 255 Suppl 1 (2008) 19-25
20. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 189 (1999) 865-870
21. Yong V.W. Differential mechanisms of action of interferon-beta and glatiramer aetate in MS. Neurology 59 (2002) 802-808
22. Ziemssen T., Kumpfel T., Schneider H., Klinkert W.E., Neuhaus O., and Hohlfeld R. Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy. J Neurol Sci 233 (2005) 109-112
23. Aharoni R., Arnon R., and Eilam R. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J Neurosci 25 (2005) 8217-8228
24. Arnon R., and Aharoni R. Neurogenesis and neuroprotection in the CNS fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders. Mol Neurobiol 36 (2007) 245-253